Cellcept
Payments companies reported to CMS as associated with Cellcept. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cellcept, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cellcept
These are the largest totals companies reported as associated with Cellcept. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Richard Furie | New Hyde Park, NY | Rheumatology | $10,042.08 |
| Kevin Winthrop | Portland, OR | Infectious Disease | $9,105.00 |
| Gabriel Contreras | Miami, FL | Nephrology (Internal Medicine) | $8,120.00 |
| Cesar Briceno | Philadelphia, PA | Ophthalmology | $5,250.00 |
| Theodore Leng | Stanford, CA | Retina Specialist | $4,200.00 |
| Atif Collins | Fresno, CA | Ophthalmic Plastic and Reconstructive Surgery | $2,875.00 |
| Jacqueline French | New York, NY | Neurology (Psychiatry & Neurology) | $2,100.00 |
| Naoka Murakami | Saint Louis, MO | Nephrology (Internal Medicine) | $1,525.00 |
| Andrea Kossler | Stanford, CA | Ophthalmic Plastic and Reconstructive Surgery | $1,150.00 |
Prescribed Cellcept?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.